Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial by Blay, Jean-Yves, Prof, Chevret, Sylvie, Prof, Le Cesne, Axel, Prof, Brahmi, Mehdi, MD, Penel, Nicolas, Prof, Cousin, Sophie, MD, Bertucci, Francois, Prof, Bompas, Emmanuelle, MD, Ryckewaert, Thomas, MD, Soibinet, Pauline, MD, Boudou-Rouquette, Pascaline, MD, Saada Bouzid, Esma, MD, Soulie, Patrick, MD, Valentin, Thibaud, MD, Lotz, Jean-Pierre, Prof, Tosi, Diego, MD, Neviere, Zoé, MD, Cancel, Mathilde, MD, Ray-Coquard, Isabelle, Prof, Gambotti, Laetitia, MD, Legrand, Frédéric, PhD, Lamrani-Ghaouti, Assia, PhD, Simon, Clotilde, PhD, Even, Caroline, MD, Massard, Christophe, Prof

Get full text

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial by Mir, Olivier, MD, Brodowicz, Thomas, MD, Italiano, Antoine, MD, Wallet, Jennifer, MSc, Blay, Jean-Yves, MD, Bertucci, François, MD, Chevreau, Christine, MD, Piperno-Neumann, Sophie, MD, Bompas, Emmanuelle, MD, Salas, Sébastien, MD, Perrin, Christophe, MD, Delcambre, Corinne, MD, Liegl-Atzwanger, Bernadette, MD, Toulmonde, Maud, MD, Dumont, Sarah, MD, Ray-Coquard, Isabelle, MD, Clisant, Stéphanie, PharmD, Taieb, Sophie, MD, Guillemet, Cécile, MD, Rios, Maria, MD, Collard, Olivier, MD, Bozec, Laurence, MD, Cupissol, Didier, MD, Saada-Bouzid, Esma, MD, Lemaignan, Christine, MD, Eisterer, Wolfgang, MD, Isambert, Nicolas, MD, Chaigneau, Loïc, MD, Cesne, Axel Le, MD, Penel, Nicolas, Dr

Get full text

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcin... by Guigay, Joël, Prof, Aupérin, Anne, MD, Fayette, Jérôme, MD, Saada-Bouzid, Esma, MD, Lafond, Cédrik, MD, Taberna, Miren, MD, Geoffrois, Lionnel, MD, Martin, Laurent, MD, Capitain, Olivier, MD, Cupissol, Didier, MD, Castanie, Hélène, MD, Vansteene, Damien, MD, Schafhausen, Philippe, MD, Johnson, Alison, MD, Even, Caroline, MD, Sire, Christian, MD, Duplomb, Sophie, MD, Evrard, Camille, MD, Delord, Jean-Pierre, Prof, Laguerre, Brigitte, MD, Zanetta, Sylvie, MD, Chevassus-Clément, Cécile, MSc, Fraslin, Aldéric, MSc, Louat, Fanny, PhD, Sinigaglia, Laura, MSc, Keilholz, Ulrich, Prof, Bourhis, Jean, Prof, Mesia, Ricard, MD

Get full text

Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, r... by Blay, Jean-Yves, Prof, Devin, Quentin, MSc, Duffaud, Florence, Prof, Toulmonde, Maud, MD, Firmin, Nelly, MD, Collard, Olivier, MD, Bompas, Emmanuelle, MD, Verret, Benjamin, MD, Ray-Coquard, Isabelle, Prof, Salas, Sebastien, Prof, Henon, Clemence, MD, Honoré, Charles, MD, Brahmi, Mehdi, MD, Dufresne, Armelle, MD, Pracht, Marc, MD, Hervieu, Alice, MD, Penel, Nicolas, Prof, Bertucci, Francois, Prof, Rios, Maria, MD, Saada-Bouzid, Esma, MD, Soibinet, Pauline, MD, Perol, David, MD, Chabaud, Sylvie, PhD, Italiano, Antoine, Prof, Cesne, Axel Le, MD

Get full text

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial by Cesne, Axel Le, MD, Blay, Jean-Yves, Prof, Domont, Julien, MD, Tresch-Bruneel, Emmanuelle, MSc, Chevreau, Christine, MD, Bertucci, François, Prof, Delcambre, Corinne, MD, Saada-Bouzid, Esma, MD, Piperno-Neumann, Sophie, MD, Bay, Jacques-Olivier, Prof, Mir, Olivier, MD, Ray-Coquard, Isabelle, Prof, Ryckewaert, Thomas, MD, Valentin, Thibaud, MD, Isambert, Nicolas, MD, Italiano, Antoine, MD, Clisant, Stéphanie, PharmD, Penel, Nicolas, Dr

Get full text

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label,... by Guigay, Joël, Prof, Ortholan, Cécile, MD, Vansteene, Damien, MD, Cupissol, Didier, MD, Even, Caroline, MD, Kaminsky, Marie-Christine, MD, Sire, Christian, MD, Blot, Emmanuel, MD, Debourdeau, Philippe, MD, Bozec, Laurence, MD, Saada-Bouzid, Esma, MD, Fayette, Jérôme, MD, Dalloz, Pierre, MD, Pointreau, Yoann, MD, Caer, Hervé Le, MD, Falandry, Claire, MD, Digue, Laurence, MD, Braccini, Antoine, MD, Lopez, Stéphane, MD, Guillet, Pierre, MD, Michel, Cécile, MSc, Cheurfa, Nadir, PhD, Schwob, Dominique, MSc, Bourhis, Jean, Prof, Mertens, Cécile, MD, Aupérin, Anne, PhD

Get full text

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm,... by Guigay, Joël, Prof, Le Caer, Hervé, MD, Ferrand, François-Régis, MD, Geoffrois, Lionel, MD, Saada-Bouzid, Esma, MD, Fayette, Jérôme, MD, Sire, Christian, MD, Cupissol, Didier, MD, Blot, Emmanuel, MD, Guillet, Pierre, MD, Pavillet, Julien, MD, Bozec, Laurence, MD, Capitain, Olivier, MD, Rolland, Frédéric, MD, Debourdeau, Philippe, MD, Pointreau, Yoann, MD, Falandry, Claire, MD, Lopez, Stéphane, MD, Coutte, Alexandre, MD, Chatellier, Thierry, MD, Dalloz, Pierre, MD, Ortholan, Cécile, MD, Michel, Cécile, MSc, Lacas, Benjamin, PhD, Cheurfa, Nadir, PhD, Schwob, Dominique, MSc, Bourhis, Jean, Prof, Mertens, Cécile, MD, Aupérin, Anne, PhD

Get full text

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, dou... by Blay, Jean-Yves, Prof, Pápai, Zsuzsanna, MD, Tolcher, Anthony W, Prof, Italiano, Antoine, MD, Cupissol, Didier, MD, López-Pousa, Antonio, MD, Chawla, Sant P, Bompas, Emmanuelle, MD, Babovic, Nada, MD, Penel, Nicolas, MD, Isambert, Nicolas, MD, Staddon, Arthur P, MD, Saâda-Bouzid, Esma, MD, Santoro, Armando, MD, Franke, Fabio A, MD, Cohen, Patrick, MD, Le-Guennec, Solenn, Demetri, George D, Prof

Get full text

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc):... by Bonvalot, Sylvie, PhD, Rutkowski, Piotr L, Prof, Thariat, Juliette, Prof, Carrère, Sébastien, MD, Ducassou, Anne, MD, Sunyach, Marie-Pierre, MD, Agoston, Peter, MD, Hong, Angela, MBBS, Mervoyer, Augustin, MD, Rastrelli, Marco, MD, Moreno, Victor, MD, Li, Rubi K, MD, Tiangco, Béatrice, MD, Herraez, Antonio Casado, MD, Gronchi, Alessandro, MD, Mangel, László, MD, Sy-Ortin, Teresa, MD, Hohenberger, Peter, Prof, de Baère, Thierry, Prof, Le Cesne, Axel, MD, Helfre, Sylvie, MD, Saada-Bouzid, Esma, MD, Borkowska, Aneta, MD, Anghel, Rodica, MD, Co, Ann, MD, Gebhart, Michael, Prof, Kantor, Guy, Prof, Montero, Angel, MD, Loong, Herbert H, MD, Vergés, Ramona, MD, Lapeire, Lore, MD, Dema, Sorin, MD, Kacso, Gabriel, MD, Austen, Lyn, MD, Moureau-Zabotto, Laurence, MD, Servois, Vincent, MD, Wardelmann, Eva, Prof, Terrier, Philippe, MD, Lazar, Alexander J, MD, Bovée, Judith V M G, Prof, Le Péchoux, Cécile, MD, Papai, Zsusanna, Prof

Get full text

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, mult... by Pautier, Patricia, MD, Italiano, Antoine, Prof, Piperno-Neumann, Sophie, MD, Chevreau, Christine, MD, Penel, Nicolas, Prof, Firmin, Nelly, MD, Boudou-Rouquette, Pascaline, MD, Bertucci, François, Prof, Balleyguier, Corinne, Prof, Lebrun-Ly, Valérie, MD, Ray-Coquard, Isabelle, Prof, Kalbacher, Elsa, MD, Bardet, Aurélie, MEng, Bompas, Emmanuelle, MD, Collard, Olivier, MD, Isambert, Nicolas, Prof, Guillemet, Cécile, MD, Rios, Maria, MD, Archambaud, Baptiste, MEng, Duffaud, Florence, Prof

Get full text